Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

被引:2091
作者
Bucciantini, M
Giannoni, E
Chiti, F
Baroni, F
Formigli, L
Zurdo, JS
Taddei, N
Ramponi, G
Dobson, CM
Stefani, M
机构
[1] Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy
[2] Univ Florence, Dipartimento Anat Istol & Med Legale, I-50134 Florence, Italy
[3] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England
关键词
D O I
10.1038/416507a
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A range of human degenerative conditions, including Alzheimer's disease, light-chain amyloidosis and the spongiform encephalopathies, is associated with the deposition in tissue of proteinaceous aggregates known as amyloid fibrils or plaques. It has been shown previously that fibrillar aggregates that are closely similar to those associated with clinical amyloidoses can be formed in vitro from proteins not connected with these diseases, including the SH3 domain from bovine phosphatidyl-inositol-3'-kinase and the amino-terminal domain of the Escherichia coli HypF protein. Here we show that species formed early in the aggregation of these non-disease-associated proteins can be inherently highly cytotoxic. This finding provides added evidence that avoidance of protein aggregation is crucial for the preservation of biological function and suggests common features in the origins of this family of protein deposition diseases.
引用
收藏
页码:507 / 511
页数:5
相关论文
共 34 条
  • [1] Amyloid β protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes
    Abe, K
    Saito, H
    [J]. NEUROSCIENCE RESEARCH, 1998, 31 (04) : 295 - 305
  • [2] SOLUTION STRUCTURE AND LIGAND-BINDING SITE OF THE SH3 DOMAIN OF THE P85-ALPHA SUBUNIT OF PHOSPHATIDYLINOSITOL 3-KINASE
    BOOKER, GW
    GOUT, I
    DOWNING, AK
    DRISCOLL, PC
    BOYD, J
    WATERFIELD, MD
    CAMPBELL, ID
    [J]. CELL, 1993, 73 (04) : 813 - 822
  • [3] Butterfield DA, 1999, METHOD ENZYMOL, V309, P746
  • [4] Designing conditions for in vitro formation of amyloid protofilaments and fibrils
    Chiti, F
    Webster, P
    Taddei, N
    Clark, A
    Stefani, M
    Ramponi, G
    Dobson, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) : 3590 - 3594
  • [5] Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N-terminal domain
    Chiti, F
    Bucciantini, M
    Capanni, C
    Taddei, N
    Dobson, CM
    Stefani, M
    [J]. PROTEIN SCIENCE, 2001, 10 (12) : 2541 - 2547
  • [6] A one-hit model of cell death in inherited neuronal degenerations
    Clarke, G
    Collins, RA
    Leavitt, BR
    Andrews, DF
    Hayden, MR
    Lumsden, CJ
    McInnes, RR
    [J]. NATURE, 2000, 406 (6792) : 195 - 199
  • [7] Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
    Conway, KA
    Lee, SJ
    Rochet, JC
    Ding, TT
    Williamson, RE
    Lansbury, PT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) : 571 - 576
  • [8] The structural basis of protein folding and its links with human disease
    Dobson, CM
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2001, 356 (1406) : 133 - 145
  • [9] Amyloid fibrils from muscle myoglobin -: Even an ordinary globular protein can assume a rogue guise if conditions are right.
    Fändrich, M
    Fletcher, MA
    Dobson, CM
    [J]. NATURE, 2001, 410 (6825) : 165 - 166
  • [10] A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils
    Fezoui, Y
    Hartley, DM
    Walsh, DM
    Selkoe, DJ
    Osterhout, JJ
    Teplow, DB
    [J]. NATURE STRUCTURAL BIOLOGY, 2000, 7 (12) : 1095 - 1099